BrainScope® has unveiled a major technological leap in neurological diagnostics with the launch of its next-generation deep learning platform, designed to advance brain health assessment across conditions such as concussion, stroke, and early Alzheimer’s detection. Building on its legacy as the developer of the first FDA-cleared AI/machine learning EEG device, BrainScope’s new Large Neural Model brings the power of large language model (LLM) breakthroughs to EEG interpretation. This eliminates the need for traditional qEEG specialists, offering real-time, automated insights that enhance both clinical speed and diagnostic precision.

The platform’s integration into BrainScope’s proprietary system enables clinicians and researchers to extract deeper, more personalized neurological insights. It supports a wide range of clinical applications—from improving triage and diagnosis in emergency settings to enabling precision-driven recruitment and monitoring in clinical trials. With the ability to detect subtle changes in brain activity, the platform opens new pathways for early detection and intervention, particularly in neurodegenerative diseases, where timely treatment can significantly impact outcomes.